Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | TDO2 | P48775 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11602791 | 0.83 | CES2 (0.54) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL1902230 | 0.81 | CES2 (0.52) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL30057873 | 0.81 | CES2 (0.52) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL23489601 | 0.80 | CES2 (0.47) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL23489602 | 0.80 | CES2 (0.47) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL7777116 | 0.80 | CES2 (0.53) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL29768740 | 0.78 | IDO1 (0.43) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL1999868 | 0.78 | IDO1 (0.43) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL213828 | 0.77 | CES2 (0.48) | CES2CES1IDO1TDO2CYP3A4 | |
| SCHEMBL625219 | 0.77 | CES2 (0.48) | CES2CES1IDO1TDO2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-211436624-U | Centrifugal machine for difluorobenzyl alcohol production | 江西犇牛医药化工有限公司 | 2020-09-08 | — | — | CN | claimed |
| CN-211371756-U | PH meter is used in difluorobenzyl alcohol production laboratory | 江西犇牛医药化工有限公司 | 2020-08-28 | — | — | CN | claimed |
| CN-211086157-U | Melting point instrument for preparing difluorobenzyl alcohol compound | 江西犇牛医药化工有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-111303179-A | Synthesis of norcantharidin carboxylic acid difluoro benzyl ester and anti-tumor application thereof | 遵义医科大学 | 2020-06-19 | — | — | CN | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-6967236-B1 | Methods of processing and synthesizing electrically conductive polymers and precursors thereof to form electrically conductive polymers having high electrical conductivity | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2005-11-22 | — | — | US | claimed |
| EP-3882235-B1 | PRODUCTION METHOD FOR ISOCYANATE COMPOUND | UNIV KOBE NAT UNIV CORP (JP) | 2025-01-22 | — | — | EP | disclosed |
| US-12060312-B2 | Production method for isocyanate compound | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2024-08-13 | — | — | US | disclosed |
| CN-111303179-B | Synthesis of norcantharidin carboxylic acid difluoro benzyl ester and anti-tumor application thereof | 遵义医科大学 | 2022-12-02 | — | — | CN | disclosed |
| CN-114835563-A | Synthetic method of 4,4' -difluorobenzophenone | 浙江中欣氟材股份有限公司 | 2022-08-02 | — | — | CN | disclosed |
| US-20220002234-A1 | PRODUCTION METHOD FOR ISOCYANATE COMPOUND | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3882235-A1 | PRODUCTION METHOD FOR ISOCYANATE COMPOUND | National University Corporation Kobe University (JP) | 2021-09-22 | — | — | EP | disclosed |
| CN-113038942-A | Composition for treating fibrotic diseases containing benzhydrylthioacetamide (Benzhydryl ttoacetamide) compound as active ingredient | 细胞离子生物医学株式会社 | 2021-06-25 | — | — | CN | disclosed |
| CN-1630645-A | 5-HT receptor ligands and uses thereof | PFIZER (US) | 2005-06-22 | — | — | CN | disclosed |
| US-5837162-A | CYCLIC ETHERS FOR LIQUID CRYSTAL DISPLAYS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1998-11-17 | — | — | US | disclosed |
| US-5626793-A | Liquid-crystalline compounds | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1997-05-06 | — | — | US | disclosed |
| WO-1993003113-A1 | LIQUID-CRYSTAL COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1993-02-18 | — | — | WO | disclosed |
| EP-0525140-A1 | LIQUID-CRYSTAL COMPOUNDS | MERCK PATENT GmbH (DE) | 1993-02-03 | — | — | EP | disclosed |
| WO-1992013928-A1 | LIQUID-CRYSTAL COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1992-08-20 | — | — | WO | disclosed |
| EP-0373531-A1 | Novel pyridobenzoxazine derivative | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1990-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12060312-B2 | Production method for isocyanate compound | IDH2, CBR3, IDH3A | CES2 1339/4885CES1 2811/4885IDO1 83/4885 |
| US-20220002234-A1 | PRODUCTION METHOD FOR ISOCYANATE COMPOUND | IDH2, CBR3, IDH3A | CES2 1339/4885CES1 2811/4885IDO1 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.